Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.0%)
USD 0.22
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.37 CAD | 24.49% |
| 2022 | -0.49 CAD | 30.99% |
| 2021 | -0.71 CAD | 0.0% |
| 2020 | -0.71 CAD | -18.33% |
| 2019 | -0.60 CAD | -22.45% |
| 2018 | -0.49 CAD | 18.33% |
| 2017 | -0.60 CAD | -42.86% |
| 2016 | -0.42 CAD | 64.71% |
| 2015 | -1.19 CAD | -16.67% |
| 2014 | -1.02 CAD | -155.0% |
| 2013 | -0.40 CAD | -11.11% |
| 2012 | -0.36 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.10 CAD | 13.55% |
| 2024 Q3 | -0.08 CAD | 15.88% |
| 2024 Q1 | -0.11 CAD | -63.2% |
| 2023 Q3 | -0.08 CAD | 31.25% |
| 2023 Q4 | -0.07 CAD | 18.3% |
| 2023 Q2 | -0.12 CAD | -9.09% |
| 2023 Q1 | -0.11 CAD | -10.0% |
| 2023 FY | - CAD | 24.49% |
| 2022 Q4 | -0.10 CAD | -6.84% |
| 2022 Q2 | -0.17 CAD | -30.77% |
| 2022 Q1 | -0.13 CAD | 7.14% |
| 2022 FY | - CAD | 30.99% |
| 2022 Q3 | -0.09 CAD | 44.94% |
| 2021 Q1 | -0.16 CAD | 27.27% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q3 | -0.17 CAD | 26.09% |
| 2021 Q4 | -0.14 CAD | 17.65% |
| 2021 Q2 | -0.23 CAD | -43.75% |
| 2020 Q2 | -0.19 CAD | -46.15% |
| 2020 Q3 | -0.15 CAD | 21.05% |
| 2020 Q4 | -0.22 CAD | -46.67% |
| 2020 FY | - CAD | -18.33% |
| 2020 Q1 | -0.13 CAD | 31.58% |
| 2019 Q3 | -0.15 CAD | -25.0% |
| 2019 Q4 | -0.19 CAD | -26.67% |
| 2019 FY | - CAD | -22.45% |
| 2019 Q1 | -0.13 CAD | 7.14% |
| 2019 Q2 | -0.12 CAD | 7.69% |
| 2018 Q1 | -0.15 CAD | -7.14% |
| 2018 FY | - CAD | 18.33% |
| 2018 Q4 | -0.14 CAD | -40.42% |
| 2018 Q3 | -0.10 CAD | 9.36% |
| 2018 Q2 | -0.11 CAD | 26.67% |
| 2017 Q2 | -0.12 CAD | 14.29% |
| 2017 FY | - CAD | -42.86% |
| 2017 Q4 | -0.14 CAD | 26.32% |
| 2017 Q3 | -0.19 CAD | -58.33% |
| 2017 Q1 | -0.14 CAD | -45.53% |
| 2016 Q2 | -0.15 CAD | -94.3% |
| 2016 FY | - CAD | 64.71% |
| 2016 Q4 | -0.10 CAD | 3.8% |
| 2016 Q3 | -0.10 CAD | 33.33% |
| 2016 Q1 | -0.08 CAD | 57.11% |
| 2015 FY | - CAD | -16.67% |
| 2015 Q2 | -0.34 CAD | 22.73% |
| 2015 Q1 | -0.44 CAD | -46.67% |
| 2015 Q4 | -0.18 CAD | 25.0% |
| 2015 Q3 | -0.24 CAD | 29.41% |
| 2014 Q2 | -0.20 CAD | -33.33% |
| 2014 FY | - CAD | -155.0% |
| 2014 Q4 | -0.30 CAD | 11.76% |
| 2014 Q3 | -0.34 CAD | -70.0% |
| 2014 Q1 | -0.15 CAD | -36.36% |
| 2013 FY | - CAD | -11.11% |
| 2013 Q4 | -0.11 CAD | 21.43% |
| 2013 Q3 | -0.14 CAD | -58.73% |
| 2013 Q2 | -0.09 CAD | -24.05% |
| 2013 Q1 | -0.07 CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |